Financial Performance - The company's operating revenue for the third quarter was ¥295,361,829.73, an increase of 5.98% compared to the same period last year[4] - The total profit for the quarter reached ¥10,718,276.35, reflecting a significant increase of 295.81% year-on-year[4] - The net profit attributable to shareholders was ¥12,042,279.58, marking a substantial growth of 606.40% compared to the previous year[4] - The net profit after deducting non-recurring gains and losses for the quarter was ¥10,175,405.65, up 625.82% year-on-year[4] - The basic earnings per share for the quarter was ¥0.07, an increase of 800.00% compared to the same period last year[5] - Total operating revenue for the first three quarters of 2025 reached ¥914,118,881.84, an increase of 14.3% compared to ¥799,799,696.65 in the same period of 2024[20] - Net profit for the first three quarters of 2025 was ¥39,475,235.25, a significant recovery from a net loss of ¥26,964,206.82 in the same period of 2024[21] - The company reported a basic and diluted earnings per share of ¥0.26 for the first three quarters of 2025, compared to a loss of ¥0.15 per share in 2024[22] - The company reported a total profit of ¥41,375,224.99 for the first three quarters of 2025, recovering from a total loss of ¥37,485,505.56 in the same period of 2024[21] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,742,043,151.50, a slight decrease of 0.12% from the end of the previous year[5] - The equity attributable to shareholders increased to ¥1,619,484,313.65, representing a growth of 2.87% compared to the previous year[5] - The company's total liabilities decreased to ¥1,128,695,956.34 in 2025 from ¥1,174,190,825.27 in 2024, indicating a reduction of approximately 3.9%[18] - Total equity attributable to shareholders increased to ¥1,619,484,313.65 in 2025 from ¥1,574,297,599.36 in 2024, reflecting a growth of 2.9%[18] - The company’s long-term borrowings decreased to ¥16,921,026.01 in 2025 from ¥27,221,624.92 in 2024, a reduction of 37.5%[18] Cash Flow - The net cash flow from operating activities for the year-to-date was -¥178,122,122.03, indicating a decline of 1,312.30% year-on-year[4] - Cash flow from operating activities showed a net outflow of ¥178,122,122.03 in the first three quarters of 2025, worsening from a net outflow of ¥12,612,234.02 in 2024[24] - Net cash flow from investment activities was $26,517,654.29, a significant improvement from a negative cash flow of $252,940,834.35 in the previous period[25] - Total cash inflow from investment activities amounted to $943,922,200.88, compared to $401,957,992.90 last year, indicating a 134% increase[25] - Cash outflow for investment activities was $917,404,546.59, up from $654,898,827.25, reflecting a 40% increase year-over-year[25] - Net cash flow from financing activities was negative at -$17,422,297.53, contrasting with a positive cash flow of $119,926,893.82 in the previous year[25] - Cash inflow from financing activities totaled $176,865,838.23, slightly up from $175,889,146.18, showing a marginal increase[25] - Cash outflow for financing activities increased to $194,288,135.76 from $55,962,252.36, representing a significant rise[25] - The net increase in cash and cash equivalents was -$167,463,015.08, compared to -$144,146,466.58 in the prior period[25] - The ending balance of cash and cash equivalents was $365,636,248.65, down from $542,202,577.97 at the end of the previous year[25] Current Assets and Receivables - As of September 30, 2025, total current assets amounted to CNY 1,646,959,861.60, an increase from CNY 1,544,491,817.38 on December 31, 2024, reflecting a growth of approximately 6.7%[16] - Cash and cash equivalents decreased to CNY 415,270,279.20 from CNY 575,009,309.85, representing a decline of about 27.8%[16] - Accounts receivable increased significantly to CNY 302,952,914.60 from CNY 131,370,198.80, marking a growth of approximately 130.1%[16] - Inventory rose to CNY 259,740,801.33 from CNY 231,412,437.26, indicating an increase of about 12.2%[16] - The company reported a significant increase in receivables financing to CNY 74,607,326.81 from CNY 30,517,737.81, representing a growth of approximately 144.5%[16] Government Subsidies - The company received government subsidies amounting to ¥4,587,822.41, which will have a lasting impact on its financial performance[9] Changes in Shareholder Structure - The company has not reported any significant changes in the shareholder structure or any related party transactions during the reporting period[15]

格科微有限公司 2025 年第三季度报告 单位：元 币种：人民币 证券代码：688728 证券简称：格科微 格科微有限公司 2025 年第三季度报告 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 第三季度财务报表是否经审计 □是 √否 重要内容提示： 一、主要财务数据 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 （一） 主要会计数据和财务指标 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 2,086,238,027 | 18.27 | 5,722,579,132 | 25 ...

公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人何小龙、主管会计工作负责人吴国屹及会计机构负责人（会计主管人员）吴从韵保证 季度报告中财务信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 华润微电子有限公司 2025 年第三季度报告 证券代码：688396 证券简称：华润微 华润微电子有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、主要财务数据 （一） 主要会计数据和财务指标 1 / 11 单位：元 币种：人民币 项目 本报告期 本报告期比上 年同期增减变 动幅度(%) 年初至报告期末 年初至报告期末 比上年同期增减 变动幅度(%) 营业收入 2,850,687,238.79 5.14 8,068,865,994.15 7.99 利润总额 226,396,047.07 0.18 583,310,390.15 6.96 归属于上市公司股东 的净利润 186, ...

Financial Performance - The company's operating revenue for the third quarter was ¥84,539,789.17, a decrease of 20.34% compared to the same period last year[4]. - The total profit for the quarter was ¥19,251,851.62, reflecting a slight increase of 1.50% year-over-year[4]. - The net profit attributable to shareholders was ¥15,568,702.17, down 14.18% from the previous year[4]. - The net profit after deducting non-recurring gains and losses was ¥12,613,691.66, a decrease of 6.61% compared to the same period last year[4]. - The net profit attributable to shareholders for the year-to-date period was ¥52,075,945.56, a decrease of 24.77% compared to the same period last year[4]. - Total operating revenue for the first three quarters of 2025 was CNY 246,038,366.58, a decrease of 13.5% compared to CNY 284,372,145.64 in the same period of 2024[18]. - Net profit for the first three quarters of 2025 was CNY 52,075,945.56, a decline of 24.8% from CNY 69,223,699.86 in the same period of 2024[19]. - Basic and diluted earnings per share for the first three quarters of 2025 were CNY 0.88, compared to CNY 1.17 in the previous year[20]. Expenses and Costs - Research and development expenses totaled ¥10,323,875.43, accounting for 12.21% of operating revenue, an increase of 0.99 percentage points year-over-year[5]. - Total operating costs for the first three quarters of 2025 were CNY 202,232,356.86, down 5.3% from CNY 213,555,356.95 in the previous year[18]. - Cash paid for employee compensation was $79,632,936.70, slightly down from $83,739,381.91, indicating a decrease of approximately 4.2%[23]. - Cash paid for the acquisition of fixed assets was $38,472,201.21, down from $46,779,879.79, indicating a decrease of approximately 17.8%[23]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,624,630,470.74, a decrease of 1.59% from the end of the previous year[5]. - Total current assets decreased to ¥2,387,635,853.77 from ¥2,445,954,658.16 year-over-year[14]. - The total liabilities amounted to CNY 516,154,930.00, down from CNY 540,623,840.13 in the previous year[16]. - Non-current liabilities totaled CNY 5,405,605.15, a decrease from CNY 5,866,451.12 in the previous year[16]. - Deferred income tax assets increased to CNY 24,411,076.20 from CNY 12,434,774.80 in the previous year[16]. Cash Flow - The company reported a cash flow from operating activities of ¥93,509,710.92 for the year-to-date period[4]. - Operating cash inflow totaled $304,471,326.52, an increase from $250,422,787.22 in the previous period, reflecting a growth of approximately 21.6%[23]. - Net cash outflow from operating activities was $210,961,615.60, compared to $256,726,871.67 previously, indicating a decrease of about 17.8%[23]. - Net cash flow from investing activities was -$147,084,517.00, an improvement from -$487,674,305.28 in the prior period, showing a reduction in losses by approximately 69.8%[23]. - Cash received from sales of goods and services in the first three quarters of 2025 was CNY 279,448,028.48, an increase from CNY 209,176,619.12 in the same period of 2024[22]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 6,922[11]. - The largest shareholder, Hangzhou Kaibit Investment Management Co., Ltd., holds 23,188,406 shares, accounting for 39.21% of total shares[11]. - The total number of shares repurchased by Zhejiang Shuangyuan Technology Co., Ltd. is 543,996, representing 0.92% of the total share capital[12]. - The company has a total of 1,522,112 unrestricted circulating shares held by Yibin Chendao New Energy Industry Equity Investment Partnership[11]. - The total number of shares held by the top 10 shareholders includes significant stakes from both institutional and individual investors[11]. - The company has not reported any changes in the participation of major shareholders in securities lending or borrowing activities[13]. Non-Recurring Gains and Losses - Non-recurring gains and losses for the quarter amounted to ¥2,955,010.51, with government subsidies contributing ¥522,581.88[7].

Financial Performance - The company's operating revenue for Q3 2025 reached ¥2,520,238,510.60, representing a 38.70% increase year-over-year[4] - Net profit attributable to shareholders was ¥48,838,048.77, a significant increase of 316.58% compared to the same period last year[4] - The basic earnings per share rose to ¥0.0149, reflecting a 312.84% increase year-over-year[4] - Total operating revenue for the current period reached ¥7,319,201,309.42, an increase of 14.4% compared to ¥6,395,792,186.36 in the previous period[23] - Net profit for the current period was a loss of ¥28,698,497.99, compared to a profit of ¥182,418,258.32 in the previous period, indicating a significant decline[24] - The company recorded a basic and diluted earnings per share of -¥0.0090, compared to ¥0.0548 in the previous period[25] - The total comprehensive income for the current period was a loss of ¥21,915,434.50, contrasting with a profit of ¥180,314,881.01 in the previous period[25] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥11,707,982,037.25, marking a 6.05% increase from the end of the previous year[4] - Total current assets amount to ¥5,413,420,861.11, an increase from ¥4,570,189,838.65 at the beginning of the period, representing a growth of approximately 18.43%[19] - Total liabilities reached ¥9,567,180,565.58, compared to ¥8,899,745,966.99 in the previous period, marking an increase of 7.5%[21] - The total equity attributable to shareholders of the parent company was ¥2,054,821,294.35, slightly down from ¥2,055,496,766.94[21] Cash Flow - Cash flow from operating activities for the year-to-date was ¥211,596,064.89, down 44.00% compared to the previous year[4] - The company reported a net cash inflow from operating activities of ¥7,721,398,327.20, an increase from ¥7,068,668,731.36 in the prior period[26] - The net cash flow from operating activities was $211,596,064.89, a decrease of 44.0% compared to $377,826,675.26 in the previous period[27] - Total cash inflow from operating activities amounted to $7,808,875,698.31, while cash outflow was $7,597,279,633.42, resulting in a net increase of $211,596,064.89[27] - Cash inflow from financing activities was $742,111,402.44, significantly higher than $186,850,924.00 in the previous period[27] - The net cash flow from financing activities improved by ¥268,923,081.67 compared to the previous year, primarily due to increased cash from borrowings[14] Shareholder Information - Total number of common shareholders at the end of the reporting period is 68,564[16] - The largest shareholder, Linyi Jinzhen Investment Holding Co., Ltd., holds 29.90% of shares, totaling 982,547,392 shares, with 875,572,863 shares pledged[16] - The company has a total of 0 preferred shareholders at the end of the reporting period[18] - The company does not have any significant changes in the top 10 shareholders due to margin trading activities[17] Expenses and Investments - Research and development expenses increased to ¥168,137,891.97 from ¥137,988,986.08, representing a growth of 22.0%[24] - Investment income decreased by 104.61% to -¥4,310,719.32, attributed to the absence of debt restructuring gains[11] - The company recorded a 420.10% increase in non-operating expenses, totaling ¥46,887,063.09, mainly due to increased litigation losses[11] Other Information - The company did not undergo an audit for the third quarter financial report[28] - The company will implement new accounting standards starting in 2025, affecting the financial statements[28]

南京栖霞建设股份有限公司 2025 年第三季度报告 证券代码：600533 证券简称：栖霞建设 南京栖霞建设股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 (一) 主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比 | | 年初至报告 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 期末比上年 | | | | 减变动幅度 | | 同期增减变 | | | | (%) | | 动幅度(%) | | 营业收入 | 678,302,721.60 | 94.22 | 4,521,79 ...

Financial Performance - The company's revenue for Q3 2025 reached ¥339,489,688.70, representing an increase of 82.01% compared to the same period last year[4] - Net profit attributable to shareholders was ¥22,431,577.10, up 48.42% year-on-year, while net profit after deducting non-recurring gains and losses was ¥22,353,496.31, an increase of 54.49%[4] - Total operating revenue for the current period reached ¥773,248,117.76, a significant increase from ¥429,435,724.97 in the previous period, representing a growth of approximately 80%[16] - Net profit for the current period was ¥67,916,644.10, slightly down from ¥69,169,035.27, reflecting a decrease of around 1.8%[17] - The company's basic earnings per share decreased to ¥0.37 from ¥0.83, a decline of approximately 55%[18] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,890,474,965.19, a decrease of 0.48% from the end of the previous year[4] - Total assets decreased to ¥2,890,474,965.19 from ¥2,904,440,164.19, a reduction of about 0.5%[15] - Total liabilities decreased to ¥911,844,074.38 from ¥1,005,183,426.82, a decline of approximately 9.3%[15] - The company's accounts payable decreased by 35.38% year-to-date, primarily due to payments made for project costs[8] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥64,952,958.26, down 27.12% compared to the previous year[4] - Operating cash inflow for the current period reached ¥571,501,797.08, a significant increase from ¥385,343,927.96 in the previous period, representing a growth of approximately 48.3%[20] - Net cash flow from operating activities decreased to ¥64,952,958.26 from ¥89,118,726.29, reflecting a decline of about 27.0%[21] - Cash inflow from investment activities totaled ¥1,352,326,992.39, slightly down from ¥1,399,031,682.89, a decrease of approximately 3.3%[21] - The net increase in cash and cash equivalents for the current period was ¥284,041,693.88, up from ¥69,772,841.49, representing a growth of approximately 305.5%[21] Shareholder Information - Total number of common shareholders at the end of the reporting period is 12,584[10] - The largest shareholder, Wang Cainan, holds 34.20% of shares, totaling 45,817,994 shares[10] - The number of shares held by the top ten shareholders includes significant stakes from both individual and institutional investors, indicating concentrated ownership[10] Research and Development - The company reported a significant increase in research and development expenses, which rose by 117.53% year-on-year, primarily due to data from the consolidated subsidiary[8] - Research and development expenses increased to ¥42,886,584.64 from ¥19,715,554.97, showing a growth of approximately 117%[16] Other Financial Metrics - The weighted average return on equity was 1.23%, a decrease of 0.15% year-on-year[4] - The company's cash and cash equivalents increased to ¥543,643,919.02 from ¥241,053,545.45, representing a growth of 125.5%[13] - Accounts receivable rose to ¥437,351,067.45 from ¥339,934,731.69, an increase of 28.7%[13] - Inventory decreased to ¥337,030,607.15 from ¥388,408,983.75, a decline of 13.2%[13] - The company reported a total of 79,536,111.11 in trading financial assets, down from 300,417,528.26, a decrease of 73.5%[13] - The company reported a decrease in other comprehensive income, with a net amount of ¥313,128.21 compared to ¥1,747,198.09 in the previous period, a decline of about 82%[18] - The total equity attributable to shareholders increased to ¥1,816,045,437.63 from ¥1,755,514,345.81, reflecting a growth of approximately 3.4%[15] Future Outlook - Future outlook and strategic initiatives will be discussed in subsequent reports, focusing on market expansion and new product development[12] Audit Information - The company did not undergo an audit for the third quarter financial report[22]

Financial Performance - Revenue for Q3 2025 reached ¥52,455,562.72, an increase of 68.47% compared to the same period last year[3] - Total profit for Q3 2025 was -¥21,249,963.37, representing a decrease of 54.96% year-on-year[3] - Net profit attributable to shareholders for Q3 2025 was -¥20,251,462.35, a decline of 55.58% compared to the previous year[3] - Operating cash flow for Q3 2025 was -¥22,168,904.60, a decrease of 34.03% year-on-year[3] - Total operating revenue for the first three quarters of 2025 reached ¥139,574,234.46, a significant increase from ¥98,283,588.99 in the same period of 2024, representing a growth of approximately 42%[18] - The operating profit for the first three quarters of 2025 was reported at -¥79,256,667.56, an improvement compared to -¥104,752,492.00 in 2024[19] - Net profit for the first three quarters of 2025 was -¥78,096,679.32, compared to -¥95,907,697.78 in the same period of 2024, indicating a reduction in losses[19] - The total comprehensive income attributable to the parent company was -76,162,854.28 CNY, compared to -95,645,454.09 CNY in the previous period, showing an improvement[20] - The company reported a basic and diluted earnings per share of -0.69 CNY, an improvement from -0.86 CNY in the prior period[20] Research and Development - R&D expenses totaled ¥18,092,442.60 in Q3 2025, down 30.50% from the previous year[4] - R&D expenses accounted for 34.49% of revenue in Q3 2025, a decrease of 49.11 percentage points year-on-year[4] - Research and development expenses for the first three quarters of 2025 amounted to ¥58,902,293.52, down from ¥72,049,404.79 in 2024, showing a decrease of approximately 18%[18] - The company optimized R&D resource allocation, focusing on market-oriented projects to enhance efficiency[8] Assets and Liabilities - Total assets at the end of Q3 2025 were ¥1,550,833,825.96, a decrease of 4.16% from the end of the previous year[4] - Total liabilities increased to ¥141,692,635.09 from ¥131,788,713.04, marking an increase of about 7%[14] - The total equity attributable to shareholders decreased to ¥1,390,519,558.42 from ¥1,465,785,417.74, reflecting a decline of approximately 5.1%[14] - Cash and cash equivalents included in current assets totaled ¥1,087,753,273.02, compared to ¥833,404,226.85 in the previous period, indicating a growth of about 30.5%[15] - The company reported a decrease in short-term borrowings to ¥10,007,777.78 from ¥6,005,600.00, reflecting a strategic reduction in debt[14] Shareholder Information - The total number of common shareholders at the end of the reporting period is 3,905[10] - Beijing Kangwei Century Biotechnology Co., Ltd. holds 50,400,000 shares, accounting for 44.80% of total shares[10] - Taizhou Kangwei Co-Creation Enterprise Management Consulting Partnership holds 21,600,000 shares, representing 19.20% of total shares[10] - The top ten shareholders do not include any shares lent through margin trading[12] - The company has no significant changes in shareholder structure compared to the previous period[12] Cash Flow - The company's cash and cash equivalents as of September 30, 2025, amount to ¥184,205,974.30, down from ¥255,466,049.27 as of December 31, 2024[12] - The net cash flow from operating activities was -71,824,555.68 CNY, an improvement from -92,827,326.52 CNY year-over-year[21] - Cash received from the sale of goods and services increased to 126,143,516.94 CNY, up from 90,526,995.55 CNY in the same period last year, representing a growth of approximately 39.2%[21] - The company incurred operating cash outflows totaling 229,309,685.83 CNY, compared to 189,799,092.17 CNY in the previous year[21] - The company received cash inflows from investment activities totaling 1,219,429,294.81 CNY, compared to 707,660,113.86 CNY in the previous year[21] - The company’s cash outflows from financing activities were 14,202,559.75 CNY, compared to 54,328,194.97 CNY in the previous year, indicating a reduction in financing costs[21] Operational Highlights - The increase in revenue was primarily driven by significant growth in nanopore sequencing services[8] - There are no other important reminders regarding the company's operational situation during the reporting period[12] - The company did not execute any mergers or acquisitions during the reporting period[20]

Financial Performance - The company's operating revenue for the third quarter was ¥130,039,526.89, a decrease of 15.87% compared to the same period last year[3]. - Total profit for the quarter was ¥12,494,752.97, down 48.16% year-on-year[3]. - Net profit attributable to shareholders was ¥10,952,688.00, reflecting a decline of 45.66% compared to the previous year[3]. - The basic earnings per share for the quarter was ¥0.08, a decrease of 55.56% year-on-year[3]. - Total operating revenue for the first three quarters of 2025 reached ¥398,180,432.24, a slight increase from ¥390,816,368.30 in the same period of 2024, representing a growth of approximately 0.93%[19]. - The net profit for the first three quarters of 2025 reached ¥58,625,749.54, an increase of 16.5% compared to ¥50,337,922.51 in the same period of 2024[20]. - Basic and diluted earnings per share for the first three quarters of 2025 were both ¥0.42, slightly up from ¥0.41 in the same period of 2024[20]. Research and Development - Research and development expenses totaled ¥7,784,426.48, accounting for 5.99% of operating revenue, an increase of 1.75 percentage points[4]. - Research and development expenses increased to ¥21,096,099.18 in 2025 from ¥19,834,731.06 in 2024, marking an increase of about 6.4%[19]. Cash Flow and Assets - The net cash flow from operating activities for the year-to-date was ¥128,296,599.37, a significant increase of 1,268.59% compared to the previous year[3]. - Cash and cash equivalents as of September 30, 2025, amounted to ¥438,226,897.19, up from ¥284,205,896.01 at the end of 2024, representing a growth of approximately 54.3%[14]. - Total assets at the end of the reporting period were ¥1,748,226,296.50, representing a 2.71% increase from the end of the previous year[4]. - Total assets as of September 30, 2025, were ¥1,748,226,296.50, compared to ¥1,702,023,099.33 at the end of 2024, showing an increase of approximately 2.7%[15]. - The company's retained earnings increased to ¥513,013,576.86 in 2025 from ¥465,769,398.40 in 2024, reflecting a growth of approximately 10.1%[16]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 8,274[9]. - The largest shareholder, Yuan Jianhua, holds 41,072,020 shares, representing 29.26% of total shares[9]. - JET (H.K.) BIOSCIENCE holds 17,547,293 shares, accounting for 12.50% of total shares[9]. - The company has a total of 10 major shareholders, with the top 10 holding significant stakes in the company[10]. Legal Matters - The company is involved in a lawsuit with Shanghai You Electronic Technology Co., Ltd. regarding a contract dispute, with a claim amount of RMB 18,441,691.80 and a penalty of RMB 1,386,000[11]. - The court ruled that Shanghai You must return RMB 11,256,957.82 to the company and pay a penalty of RMB 922,084.59[11]. - The company is also in a legal dispute with Shenzhen Hesheng Medical Technology Co., Ltd. over a mold procurement contract, with a claim amount of RMB 10,340,829.00 and damages of RMB 644,911[12]. - The court ordered Hesheng Medical to return the claimed amount and compensate for damages, but Hesheng Medical has appealed the decision[12]. - The company has had part of its funds frozen amounting to RMB 11,473,149.78 due to ongoing litigation[13]. - The company is actively managing its legal disputes to mitigate financial impacts and protect shareholder interests[11]. Operating Costs - Total operating costs for the first three quarters of 2025 were ¥340,567,157.86, compared to ¥329,050,630.04 in 2024, indicating an increase of about 3.8%[19]. - The total cash outflow from operating activities in the first three quarters of 2025 was ¥392,674,512.47, a decrease from ¥423,922,874.13 in the same period of 2024[22].

烟台亚通精工机械股份有限公司 2025 年第三季度报告 证券代码：603190 证券简称：亚通精工 烟台亚通精工机械股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 454,077,620.35 | 27.12 | 1,28 ...